Jurkat CD19-, eGFP
Item Information
Catalog #
Size
Price
Description
The Jurkat cell line (originally called JM) was established in the late 1970s from the peripheral blood of a 14-year-old boy with T cell leukemia. Jurkat cells which are CD19-negative are generated using lentiviral GFP transduction (CD19- eGFP cells). These cells can be used as a negative control target cells for CAR-T with CD19-CAR-T cells.
Product Overview
Storage
-80°C; liquid nitrogen
For Research Use Only. Not for use in diagnostic procedures.